|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 14 of 15 found articles
| Title: |
Treatment Rationale and Study Design for the PointBreak Study: A Randomized, Open-label Phase III Study of Pemetrexed/Carboplatin/Bevacizumab Followed by Maintenance Pemetrexed/Bevacizumab Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer |
| Author: |
Patel, Jyoti D. Bonomi, Philip Socinski, Mark A. Govindan, Ramaswamy Hong, Shengyan Obasaju, Coleman Pennella, Eduardo J. Girvan, Allicia C. Guba, Susan C. |
| Appeared in: |
Clinical lung cancer |
| Paging: | Volume 10 (2009) nr. 4 pages 5 p. |
| Year: |
2009 |
| Contents: | |
| Publisher: |
Elsevier Inc. |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 14 of 15 found articles
| << previous | next >> |